Last Updated: November 13, 2026

SUMATRIPTAN SUCCINATE (AUTOINJECTOR) Drug Patent Profile

« Back to Dashboard

When do Sumatriptan Succinate (autoinjector) patents expire, and what generic alternatives are available?

Sumatriptan Succinate (autoinjector) is a drug marketed by Alembic, Antares Pharma Inc, Dr Reddys, Onesource Specialty, and Sun Pharm. and is included in five NDAs.

The generic ingredient in SUMATRIPTAN SUCCINATE (AUTOINJECTOR) is sumatriptan succinate. Thirty-six suppliers are listed for this compound. Additional details are available on the sumatriptan succinate profile page.

DrugPatentWatch^® Litigation and Generic Entry Outlook for Sumatriptan Succinate (autoinjector)

A generic version of SUMATRIPTAN SUCCINATE (AUTOINJECTOR) was approved as sumatriptan succinate by HIKMA on February 6^th, 2009.

Start Trial

AI Deep Research

Questions you can ask:

What is the 5 year forecast for SUMATRIPTAN SUCCINATE (AUTOINJECTOR)?
What are the global sales for SUMATRIPTAN SUCCINATE (AUTOINJECTOR)?
What is Average Wholesale Price for SUMATRIPTAN SUCCINATE (AUTOINJECTOR)?

Summary for SUMATRIPTAN SUCCINATE (AUTOINJECTOR)

US Patents:	0
Applicants:	5
NDAs:	5

US Patents and Regulatory Information for SUMATRIPTAN SUCCINATE (AUTOINJECTOR)

+ Get email alerts for changes to this table

Subscribe to access the full database, or Start Trial
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Alembic	SUMATRIPTAN SUCCINATE (AUTOINJECTOR)	sumatriptan succinate	SOLUTION;SUBCUTANEOUS	213518-001	Nov 6, 2025	AB	RX	No	No	⤷ Start Trial	⤷ Start Trial				⤷ Start Trial
Sun Pharm	SUMATRIPTAN SUCCINATE (AUTOINJECTOR)	sumatriptan succinate	SOLUTION;SUBCUTANEOUS	090358-001	Jun 21, 2011	AB	RX	No	No	⤷ Start Trial	⤷ Start Trial				⤷ Start Trial
Antares Pharma Inc	SUMATRIPTAN SUCCINATE (AUTOINJECTOR)	sumatriptan succinate	SOLUTION;SUBCUTANEOUS	078319-002	Dec 10, 2015		DISCN	No	No	⤷ Start Trial	⤷ Start Trial				⤷ Start Trial
Alembic	SUMATRIPTAN SUCCINATE (AUTOINJECTOR)	sumatriptan succinate	SOLUTION;SUBCUTANEOUS	213518-002	Nov 6, 2025	AB	RX	No	No	⤷ Start Trial	⤷ Start Trial				⤷ Start Trial
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>TE	>Type	>RLD	>RS	>Patent No.	>Patent Expiration	>Product	>Substance	>Delist Req.	>Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.